benchtop PCR

Illumina has acquired real-time PCR and nucleic acid-analysis firm Helixis for up to $105 million, and has launched a new benchtop PCR instrument developed by Helixis that it said will cost about a quarter the price of existing systems while delivering the same level of performance.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.